M3, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,883 JPY | -1.18% |
|
-0.03% | -19.29% |
| Apr. 17 | Dai-ichi Life CEO expects unsolicited takeovers to become common practice in Japan | RE |
| Feb. 29 | M3, Inc. Provides Dividend Guidance for the Fiscal Year Ended March 31, 2024 | CI |
ETFs positioned on M3, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 8.65% | 5 M€ | -6.80% | ||
| 5.00% | 6 M€ | +2.74% | ||
| 1.71% | 19 M€ | +2.79% | ||
| 1.32% | 67,864 M€ | +13.39% | ||
| 1.14% | 60 M€ | +13.88% | ||
| 1.10% | 31,732 M€ | +13.41% | - | |
| 1.09% | 1,198 M€ | +12.62% | - | |
| 1.06% | 11 M€ | +10.19% | - | |
| 0.93% | 16,729 M€ | +12.49% | - | |
| 0.81% | 251 M€ | +13.17% | ||
| 0.64% | 4 M€ | +13.95% | ||
| 0.41% | 26 M€ | +20.74% | ||
| 0.37% | 73 M€ | +11.61% | ||
| 0.33% | 18 M€ | +16.15% | - | |
| 0.31% | 10,207 M€ | +13.95% | ||
| 0.31% | 5,115 M€ | +13.67% | ||
| 0.23% | 20,721 M€ | +12.65% | - | |
| 0.23% | 66,066 M€ | +13.80% | - | |
| 0.23% | 144,586 M€ | +13.76% | ||
| 0.17% | 2 M€ | +9.19% | - | |
| 0.17% | 2 M€ | -.--% | - | |
| 0.06% | 7 M€ | +1.70% | - | |
| 0.05% | 10 M€ | -3.35% | - | |
| 0.04% | 0 M€ | 0.00% | - | |
| 0.03% | 31 M€ | +3.05% | - | |
| 0.02% | 389 M€ | +5.50% | - | |
| 0.02% | 34 M€ | +5.94% | - | |
| 0.02% | 205 M€ | -.--% | ||
| 0.02% | 206 M€ | -.--% |
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
Sector
Internet Services
Calendar
2024-04-25
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
1,906
JPY
Average target price
2,565
JPY
Spread / Average Target
+34.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -19.29% | 8.34B | |
| +15.60% | 409B | |
| +12.65% | 144B | |
| +19.61% | 103B | |
| +14.55% | 82.83B | |
| +49.66% | 55.78B | |
| +28.18% | 51.21B | |
| +5.22% | 37.55B | |
| +17.51% | 32.28B | |
| -11.31% | 22.42B |
- Stock Market
- Equities
- 2413 Stock
- Funds and ETFs M3, Inc.
